Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2026 06:00 ET | Source: Kuntarahoitus Oyj

Kuntarahoitus Oyj eräännyttää ennenaikaisesti osana joukkovelkakirjaohjelmaa liikkeeseenlasketun joukkovelkakirjalainan

Kuntarahoitus OyjPörssitiedote4.5.2026 klo 13.00 Kuntarahoitus Oyj eräännyttää ennenaikaisesti osana joukkovelkakirjaohjelmaa liikkeeseenlasketun joukkovelkakirjalainan Kuntarahoitus Oyj käyttää...
May 04, 2026 03:00 ET | Source: Municipality Finance Plc

Municipality Finance issues a USD 50 million tap under its MTN programme

Municipality Finance PlcStock exchange release 4 May 2026 at 10:00 am (EEST) Municipality Finance issues a USD 50 million tap under its MTN programme On 5 May 2026 Municipality Finance Plc issues a...
May 04, 2026 03:00 ET | Source: Kuntarahoitus Oyj

Kuntarahoitus laskee liikkeeseen 50 miljoonan Yhdysvaltain dollarin lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa

Kuntarahoitus OyjPörssitiedote4.5.2026 klo 10.00 Kuntarahoitus laskee liikkeeseen 50 miljoonan Yhdysvaltain dollarin lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj...
May 04, 2026 01:00 ET | Source: Molecular Partners

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

ZURICH-SCHLIEREN, Switzerland and Concord, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of...
May 01, 2026 07:00 ET | Source: Molecular Partners

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Positive Phase 1 data confirm MP0317’s tumor-localized CD40 activation with a favorable safety profile in patients with advanced cancer typesPharmacokinetic profile of MP0317 well suited for...
April 30, 2026 16:54 ET | Source: Wisekey International Holding Ltd.

WISeKey Reports Audited Full Year 2025 Financial Results

WISeKey Reports Audited Full Year 2025 Financial Results Schedules Conference Call for Monday, May 4 at 9:00am EDT Audited FY 2025 revenue of $19.3 million, representing 62% growth...
April 30, 2026 07:00 ET | Source: Novartis Pharma AG

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew active pharmaceutical ingredients facility in North Carolina...
April 30, 2026 07:00 ET | Source: Novartis Pharma AG

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patientsNew active pharmaceutical ingredients facility in North Carolina...
April 30, 2026 03:00 ET | Source: 21Shares

21shares Partners with Kaiko Indices to Enhance Pricing Precision Across European Single-Asset Crypto Suite

Zurich, 30 April 2026 – 21shares, a global leader in cryptocurrency exchange-traded products (ETPs), has successfully transitioned the underlying index provider for a broad segment of its European...
April 30, 2026 01:00 ET | Source: Santhera Pharmaceuticals Holding AG

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, April 30, 2026 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent...